Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metformin: review of epidemiology and mechanisms of action in pancreatic cancer
Guido Eibl, Enrique Rozengurt
Cancer and Metastasis Reviews (2021) Vol. 40, Iss. 3, pp. 865-878
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Metformin and cancer hallmarks: shedding new lights on therapeutic repurposing
Hua Yu, Yue Zheng, Yiran Yao, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 96
Barriers and opportunities for gemcitabine in pancreatic cancer therapy
Alica K. Beutel, Christopher J. Halbrook
AJP Cell Physiology (2022) Vol. 324, Iss. 2, pp. C540-C552
Open Access | Times Cited: 73
Metformin: A Dual-Role Player in Cancer Treatment and Prevention
Mariam Ahmed Galal, Mohammed Al-Rimawi, Abdurrahman Hajeer, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4083-4083
Open Access | Times Cited: 17
Metformin in therapeutic applications in human diseases: its mechanism of action and clinical study
Yang Du, Yajuan Zhu, Yixin Zhou, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 41
The GLP-1R agonist semaglutide reshapes pancreatic cancer associated fibroblasts reducing collagen proline hydroxylation and favoring T lymphocyte infiltration
Chiara Cencioni, Silvia Malatesta, Virginia Vigiano Benedetti, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 1
Pancreatic endocrine and exocrine signaling and crosstalk in physiological and pathological status
Chenglin Hu, Yuan Chen, Xinpeng Yin, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Obesity and Pancreatic Cancer: Insight into Mechanisms
Guido Eibl, Enrique Rozengurt
Cancers (2021) Vol. 13, Iss. 20, pp. 5067-5067
Open Access | Times Cited: 41
Recent advances of mitochondrial complex I inhibitors for cancer therapy: Current status and future perspectives
Yang Zhou, Jiao Zou, Jing Xu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 251, pp. 115219-115219
Closed Access | Times Cited: 21
Cancer Metabolism as a Therapeutic Target and Review of Interventions
Matthew Halma, Jack A. Tuszyński, Paul E. Marik
Nutrients (2023) Vol. 15, Iss. 19, pp. 4245-4245
Open Access | Times Cited: 20
Effects of metformin on cancers in experimental and clinical studies: Focusing on autophagy and AMPK/mTOR signaling pathways
Mohammad Yasin Zamanian, Maryam Golmohammadi, Alexey Yumashev, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 4
Open Access | Times Cited: 8
The multifaceted roles of mitochondria at the crossroads of cell life and death in cancer
Fabrizio Fontana, Patrízia Limonta
Free Radical Biology and Medicine (2021) Vol. 176, pp. 203-221
Closed Access | Times Cited: 33
Metformin: A promising drug for human cancers (Review)
Hongnian Wu, Dan Huang, Hong Zhou, et al.
Oncology Letters (2022) Vol. 24, Iss. 1
Open Access | Times Cited: 27
The involvement of the mitochondrial membrane in drug delivery
Yinghui Huang, Wenhui Ji, Jiaxin Zhang, et al.
Acta Biomaterialia (2024) Vol. 176, pp. 28-50
Open Access | Times Cited: 5
Association of glucose-lowering drug target and risk of gastrointestinal cancer: a mendelian randomization study
Yi Yang, Bo Chen, Chongming Zheng, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Hypoglycemic agents and incidence of pancreatic cancer in diabetic patients: a meta-analysis
Zimo Zhao, Xinyi He, Yan Sun
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 6
Diabetes Mellitus and Pancreatic Ductal Adenocarcinoma—Prevalence, Clinicopathological Variables, and Clinical Outcomes
Anna Badowska-Kozakiewicz, Marta Fudalej, Daria Kwaśniewska, et al.
Cancers (2022) Vol. 14, Iss. 12, pp. 2840-2840
Open Access | Times Cited: 9
The NAMPT Inhibitor FK866 Increases Metformin Sensitivity in Pancreatic Cancer Cells
Maxime Parisotto, Nhung Vuong, Paloma Kalegari, et al.
Cancers (2022) Vol. 14, Iss. 22, pp. 5597-5597
Open Access | Times Cited: 9
Obesity associated pancreatic ductal adenocarcinoma: Therapeutic challenges
Mundla Srilatha, Rama Rao Malla, Megha Priya Adem, et al.
Seminars in Cancer Biology (2023) Vol. 97, pp. 12-20
Closed Access | Times Cited: 5
Low dosage combination treatment with metformin and simvastatin inhibits obesity-promoted pancreatic cancer development in male KrasG12D mice
Yaroslav Teper, Linda Ye, Richard T. Waldron, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Effects of metformin on cancers in experimental and clinical studies: Focusing on autophagy and AMPK/mTOR Signaling Pathways
Mohammad Yasin Zamanian, Maryam Golmohammadi, Alexey Yumashev, et al.
Authorea (Authorea) (2024)
Open Access | Times Cited: 1
Priority list of pharmaceutical active compounds in aquatic environments of Mexico considering their occurrence, environmental and human health risks
Rafael Hernández-Tenorio, Minerva Villanueva-Rodríguez, Jorge Luis Guzmán‐Mar, et al.
Environmental Toxicology and Pharmacology (2024) Vol. 110, pp. 104502-104502
Closed Access | Times Cited: 1
Effect of Sodium-Glucose Co-Transporter 2 Inhibitors Combined with Metformin on Pancreatic Cancer Cell Lines
André Cristovão, Nelson Andrade, Fátima Martel, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 9932-9932
Open Access | Times Cited: 1
Metformin protects prepubertal mice ovarian reserve against cyclophosphamide via regulation of the PI3K/Akt/mTOR signaling pathway and Yap-1
Negin Zatalian, Azam Dalman, Parvaneh Afsharian, et al.
Journal of Ovarian Research (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Quo vadis PGRMC? Grand-Scale Biology in Human Health and Disease
Michael A. Cahill
Frontiers in Bioscience-Landmark (2022) Vol. 27, Iss. 11, pp. 318-318
Open Access | Times Cited: 7
The NAMPT Inhibitor FK866 Increases Metformin Sensitivity in Pancreatic Cancer Cells
Maxime Parisotto, Nhung Vuong, Paloma Kalegari, et al.
(2022)
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top